Kirsten comments on High Time For Drug Policy Reform. Part 4/​4: Estimating Cost-Effectiveness vs Other Causes; What EA Should Do Next

[Kirsten]

Are the drugs you’re talking about actually cheaper than existing treatments for depression? That surprised me a lot.